Sunil Saxena, MD
Child & Adolescent Psychiatry · White Plains, NYNPI 1346259637
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 308 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 308 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$962
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$875
- Lundbeck LLC$661
- Sunovion Pharmaceuticals Inc.$570
- AbbVie$518
- Takeda Pharmaceuticals U.S.A., Inc.$390
- plus $2K from 19 others
What the payments were for
- Food & beverage$6,383100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 47 | $962 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 36 | $875 |
| Lundbeck LLC | 40 | $661 |
| Sunovion Pharmaceuticals Inc. | 30 | $570 |
| AbbVie | 26 | $518 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $390 |
| Corium, LLC | 14 | $328 |
| Neurocrine Biosciences, Inc. | 10 | $249 |
| Indivior Inc. | 11 | $216 |
| Orexo US, Inc. | 12 | $199 |
| Tris Pharma Inc | 10 | $192 |
| Otsuka America Pharmaceutical, Inc. | 8 | $179 |
| Adlon Therapeutics L.p. | 8 | $174 |
| Ironshore Pharmaceuticals Inc. | 7 | $163 |
| Shire North American Group Inc | 8 | $156 |
| Johnson & Johnson | 2 | $146 |
| Supernus Pharmaceuticals, Inc. | 5 | $130 |
| Braeburn Inc. | 4 | $100 |
| Arbor Pharmaceuticals, Inc. | 3 | $55 |
| MDD US Operations, LLC | 3 | $43 |
| Neuronetics, Inc. | 1 | $24 |
| Bausch Health US, LLC | 1 | $19 |
| Novo Nordisk | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$122
How this compares
$6,398 in reported general payments places this provider in the 90th percentile of 317 child & adolescent psychiatry providers in New York.
See all child & adolescent psychiatry providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 168 | $19,077 |
| Aripiprazole | 53 | $6,617 |
| Buprenorphine Hcl | 40 | $2,621 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 42 | $2,244 |
| Bupropion XlBupropion Hcl | 98 | $2,221 |
| Lurasidone Hcl | 14 | $2,016 |
| Clonazepam | 162 | $1,434 |
| Trazodone Hcl | 145 | $1,349 |
| Duloxetine Hcl | 102 | $1,308 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 40 | $1,054 |
| Gabapentin | 57 | $981 |
| Olanzapine | 46 | $956 |
| Lamotrigine | 90 | $885 |
| Quetiapine Fumarate | 68 | $773 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 13 | $762 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in White Plains
- Parinda ParikhWhite Plains$185K
- Jonathan WachtelWhite Plains$7K
- Matthew LorberNew York$398K
- Mitchell CabisudoNew Windsor$346K
- Jeffrey NewcornNew York$165K
- John MarinoCanandaigua$70K
- Iliyan IvanovNew York$38K
- Melvin OatisNew York$35K
- Vijay PampanaMiddletown$19K
- Marc ReitmanHuntington$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.